Literature DB >> 3011048

Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.

J Vincent, H L Elliott, P A Meredith, J L Reid.   

Abstract

The possible racial differences in alpha 1-adrenoceptor responsiveness and the blood pressure and heart rate responses following alpha 1-adrenoceptor antagonism with trimazosin have been investigated in matched groups of six Caucasians and six Nigerians. There were no significant differences between the racial groups in the blood pressure and heart rate responses to oral (200 mg) and intravenous (100 mg) trimazosin. alpha 1-adrenoceptor responsiveness was similar in both groups after placebo and following both active treatments. There were only minor pharmacokinetic differences with the Caucasians having a larger volume of distribution, and a longer terminal elimination half-life for the metabolite, 1-hydroxy-trimazosin. These results suggest a similarity in peripheral vascular alpha 1-adrenoceptor mechanisms and show no major significant racial differences in the pharmacokinetics and pharmacodynamics of trimazosin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011048      PMCID: PMC1400935          DOI: 10.1111/j.1365-2125.1986.tb05214.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  THE EYE OF THE WEST AFRICAN NEGRO.

Authors:  J G Scott
Journal:  Br J Ophthalmol       Date:  1945-01       Impact factor: 4.638

2.  Environmental effects on antipyrine half-life in man.

Authors:  H S Fraser; J C Mucklow; C J Bulpitt; C Khan; G Mould; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  Ineffectiveness of propranolol in hypertensive Jamaicans.

Authors:  G S Humphreys; D G Delvin
Journal:  Br Med J       Date:  1968-06-08

4.  Propranolol in the South African non-white hypertensive patient.

Authors:  Y K Seedat; J Reddy
Journal:  S Afr Med J       Date:  1971-03-13

5.  The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection.

Authors:  M A Hughes; P A Meredith; H L Elliott
Journal:  J Pharmacol Methods       Date:  1984-08

Review 6.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

7.  Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate, and protein.

Authors:  K E Anderson; A H Conney; A Kappas
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

8.  Comparison of trimazosin and methyldopa in hypertension.

Authors:  W S Aronow; J Tobis; D Hughes; J Siegel; J Easthope
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

9.  Placebo-controlled, double-blind clinical trial of alprenolol in African hypertensive patients.

Authors:  L A Salako; A O Falase; A F Aderounmu
Journal:  Curr Med Res Opin       Date:  1979       Impact factor: 2.580

10.  Diphenhydramine in Orientals and Caucasians.

Authors:  R Spector; A K Choudhury; C K Chiang; M J Goldberg; M M Ghoneim
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

View more
  2 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 2.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.